Preparation and characterization of magnetic thermosensitive fluorouracil micelles

被引:7
作者
Zhang, Min [1 ]
Jin, Xueqin [1 ]
Gou, Guojing [1 ]
机构
[1] Ningxia Med Univ, Coll Pharm, Dept Pharm, Yinchuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Block copolymers; micelle; magnetic thermosensitive drug delivery system; core-shell structure; temperature-controlled release; HYDROXIDE; NANOCOMPOSITES; NANOPARTICLES;
D O I
10.1080/09205063.2016.1162626
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this study, we synthesized P(NIPAM-co-DMAM)-b-PLA polymers with free radical polymerization and ring-opening addition polymerization, and immediately assembled dextran magnetic layered double hydroxide fluorouracil' (DMF) magnetic particles into the core of the amphiphilic polymer micelles with synchronous hydration and dialysis, to generate a magnetic thermosensitive fluorouracil drug delivery system. The basic properties of the micelle particles, such as the core-shell-type structure, size, and zeta potential, were studied with H-1-NMR, FTIR, TEM, TGA, laser nanoparticle size analysis, and other characterization techniques. The thermosensitivity of the micelles was investigated by measuring parameters such as the lower critical solution temperature (LCST) and the relationship between the particle size variation and temperature. The drug release curves for the micelles at different temperatures were constructed with a dialysis method. The LCST of the triblock polymers was 42 degrees C. The particle sizes of the blank micelles and DMF-loaded micelles were 493.6 +/- 1.8nm and 464.9 +/- 4.1nm, respectively, at 25 degrees C. When the temperature was higher than LSCT, a contraction phase change in the micelle structure occurred, a significant characteristic of the core-shell-type structure, and reversible phase transition phenomena. The release behavior of the drug-loaded micelles showed obvious variations with temperature. Therefore, the magnetic thermosensitive fluorouracil drug delivery system has a good magnetic response and excellent temperature controlled release characteristics, so it can be used as a drug delivery system in magnetically and thermally targeted chemotherapy for tumors.
引用
收藏
页码:773 / 791
页数:19
相关论文
共 34 条
  • [1] Ai FR, 2010, CHEM J CHINESE U, V31, P1701
  • [2] [Anonymous], 2011, [No title captured], Patent No. 101607091
  • [3] [Anonymous], 2009, [No title captured], Patent No. 2009101173717
  • [4] [Anonymous], 2015, [No title captured], Patent No. 103356483
  • [5] [Anonymous], 2012, [No title captured], Patent No. 101607088
  • [6] [Anonymous], 2013, [No title captured], Patent No. 2013103195774
  • [7] [Anonymous], 2015, [No title captured], Patent No. 103356484
  • [8] [Anonymous], 2009, [No title captured], Patent No. 2009101173721
  • [9] [Anonymous], 2013, [No title captured], Patent No. 201310319576
  • [10] Cao Y, 2010, MAT REV, V24, P112